Rani Therapeutics Holdings, Inc. (RANI)
0.6406
-0.04
(-5.79%)
USD |
NASDAQ |
Oct 16, 16:00
0.6392
0.00 (0.00%)
After-Hours: 20:00
Rani Therapeutics Holdings Net Income (Quarterly) : -8.421M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.421M |
| March 31, 2026 | -8.015M |
| December 31, 2025 | -9.075M |
| September 30, 2025 | -7.914M |
| June 30, 2025 | -11.22M |
| March 31, 2025 | -12.74M |
| December 31, 2024 | -15.72M |
| September 30, 2024 | -12.72M |
| June 30, 2024 | -13.36M |
| March 31, 2024 | -14.78M |
| December 31, 2023 | -14.06M |
| September 30, 2023 | -18.33M |
| June 30, 2023 | -18.66M |
| Date | Value |
|---|---|
| March 31, 2023 | -16.83M |
| December 31, 2022 | -17.34M |
| September 30, 2022 | -16.21M |
| June 30, 2022 | -15.97M |
| March 31, 2022 | -13.83M |
| December 31, 2021 | -13.30M |
| September 30, 2021 | -28.70M |
| June 30, 2021 | -5.485M |
| March 31, 2021 | -5.598M |
| September 30, 2020 | -2.883M |
| June 30, 2020 | -2.714M |
| March 31, 2020 | -5.35M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | 169.40M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -158.99M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.708M |
| Total Expenses (Quarterly) | 9.099M |
| EPS Diluted (Quarterly) | -0.0395 |
| Enterprise Value | 30.78M |
| Gross Profit Margin (Quarterly) | 88.29% |
| Profit Margin (Quarterly) | -493.0% |
| Earnings Yield | -41.40% |
| Normalized Earnings Yield | -40.96 |